Candriam S.C.A. Sells 12,989 Shares of Chemed Corporation $CHE

Candriam S.C.A. cut its stake in shares of Chemed Corporation (NYSE:CHE) by 23.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 43,242 shares of the company’s stock after selling 12,989 shares during the quarter. Candriam S.C.A.’s holdings in Chemed were worth $16,334,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Los Angeles Capital Management LLC bought a new stake in Chemed during the fourth quarter valued at about $26,000. Monetary Solutions Ltd purchased a new position in Chemed in the 4th quarter worth approximately $25,000. BOK Financial Private Wealth Inc. purchased a new position in Chemed in the 4th quarter worth approximately $27,000. Global Retirement Partners LLC boosted its stake in Chemed by 200.0% in the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares during the period. Finally, Geneos Wealth Management Inc. grew its holdings in Chemed by 330.4% during the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after buying an additional 76 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

CHE has been the subject of several research reports. Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Bank of America upped their price objective on Chemed from $450.00 to $510.00 and gave the stock a “neutral” rating in a report on Thursday. Royal Bank Of Canada increased their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, April 29th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $480.25.

Chemed Trading Down 0.6%

Shares of NYSE:CHE traded down $2.70 on Friday, hitting $487.76. 143,289 shares of the company’s stock were exchanged, compared to its average volume of 193,784. The stock has a market capitalization of $6.47 billion, a price-to-earnings ratio of 26.58, a price-to-earnings-growth ratio of 1.80 and a beta of 0.52. Chemed Corporation has a 12 month low of $365.20 and a 12 month high of $493.47. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. The business’s 50 day simple moving average is $443.16 and its two-hundred day simple moving average is $428.70.

Chemed (NYSE:CHE) last issued its earnings results on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same period in the prior year, the firm earned $5.63 EPS. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. Analysts anticipate that Chemed Corporation will post 22.67 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend was Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Insider Buying and Selling

In other news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total value of $602,553.51. Following the transaction, the director directly owned 4,578 shares in the company, valued at approximately $2,047,876.74. This trade represents a 22.73% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. The trade was a 2.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 3.33% of the company’s stock.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.